Moreover, low NR1H3 expression was correlated with poorer prognosis of RFS in basal (p = 5.3e-6), luminal A (p = 3.0e-4), luminal B (p = 0.002) and HER2+ breast cancer patients (p = 0.0003) (Figure 2). The gene discussed is NR1H3; the disease is breast cancer.